Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

Omics-based tracking of Pseudomonas aeruginosa persistence in "eradicated" cystic fibrosis patients.

Research output: Contribution to journalJournal articleResearchpeer-review

  1. COVID-19: guidance on palliative care from a European Respiratory Society international task force

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Morbidity and mortality in carriers of the cystic fibrosis mutation CFTR Phe508del in the general population

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. The DisEntangling Chronic Obstructive pulmonary Disease Exacerbations clinical trials NETwork (DECODE-NET): rationale and vision

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Clinical considerations in individuals with α1-antitrypsin PI*SZ genotype

    Research output: Contribution to journalReviewpeer-review

  5. The effect of exacerbation history on outcomes in the IMPACT trial

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. Bacterial persisters in long-term infection: Emergence and fitness in a complex host environment

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Patients with cystic fibrosis and advanced lung disease benefit from lumacaftor/ivacaftor treatment

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Lung clearance index-triggered intervention in children with cystic fibrosis - A randomised pilot study

    Research output: Contribution to journalJournal articleResearchpeer-review

View graph of relations

Whenever Pseudomonas aeruginosa is cultured from cystic fibrosis (CF) patient airways, the primary goal is eradication by antibiotic therapy. Success is defined by ≥6 months of negative bacterial airway cultures. However, we suspect that P. aeruginosa persists in airways without clinical detection for long periods.Out of 298 P. aeruginosa-infected Copenhagen CF patients, we identified 80 with complete P. aeruginosa monitoring records and measured their maximum P. aeruginosa-free eradication periods (MEP). Isolates from 72 patients were whole-genome sequenced (n=567) and clone typed. Select isolate relatedness was examined through phylogenetic analysis and phenotypic multivariate modelling.69 (86%) patients exhibited eradication in the monitoring period (2002-2018). Sequenced isolates bridged the MEP of 42 patients, and the same clone type persisted over the MEP in 18 (43%) patients. Patients with failed eradication were on average treated more intensively with antibiotics, but this may be linked to their more severe pre-MEP infection trajectories. Of the 42 patients, 26 also had sinus surgery; the majority (n=15) showed MEPs adjacent to surgery, and only five had persisting clone types. Importantly, combined phylogenetic-phenomic evaluation suggests that persisting clone types are a result of re-emergence of the same strain rather than re-infection from the environment, and similar relatedness is exhibited by paired lower and upper airway samples and in transmission cases.In conclusion, nearly half of CF patients with supposed eradication may not truly be cleared of their original bacteria according to omics-based monitoring. This distinct cohort that is persistently infected would probably benefit from tailored antibiotic therapy.

Original languageEnglish
JournalThe European respiratory journal
Volume57
Issue number4
ISSN0903-1936
DOIs
Publication statusPublished - Apr 2021

ID: 62033538